UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹992 Cr | ₹738 Cr | ₹640 Cr | ₹552 Cr | ₹506 Cr |
What is the latest Total Current Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹992 Cr |
| Mar2024 | ₹738 Cr |
| Mar2023 | ₹640 Cr |
| Mar2022 | ₹552 Cr |
| Mar2021 | ₹506 Cr |
How is Total Current Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹992 Cr | 34.49 | |
| Mar2024 | ₹738 Cr | 15.32 | |
| Mar2023 | ₹640 Cr | 15.84 | |
| Mar2022 | ₹552 Cr | 9.17 | |
| Mar2021 | ₹506 Cr | - | |
Compare Total Current Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,137.0 Cr | 0.6% | 20.5% | -28.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 0.6% |
20.5% |
-28.4% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses